quinuclidines has been researched along with Acute Lymphoid Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrahmsen, L; Bianchi, J; Bykov, VJN; Ceder, S; Cheteh, EH; Clemons, NJ; Eriksson, SE; Fujihara, KM; Liang, YY; Nordlund, P; Rudd, SG; Wiman, KG; Zhang, SM | 1 |
| Mamoudou, AD; Nadaraja, S; Rosthoej, S; Schroeder, H; Thomassen, H; Wehner, PS | 1 |
1 trial(s) available for quinuclidines and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Palonosetron for the prevention of nausea and vomiting in children with acute lymphoblastic leukemia treated with high dose methotrexate.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Child; Child, Preschool; Denmark; Female; Humans; Isoquinolines; Male; Methotrexate; Nausea; Palonosetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinuclidines; Serotonin Antagonists; Time Factors; Vomiting | 2012 |
1 other study(ies) available for quinuclidines and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Humans; Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinuclidines; Tumor Suppressor Protein p53 | 2021 |